Facilitation of retrovirus-mediated gene transfer into hematopoietic stem and progenitor cells and peripheral blood T-lymphocytes utilizing recombinant fibronectin fragments

Current Opinion in Molecular Therapeutics

Volumn 1, Issue 5, 1999, Pages 595-604

  Pollok, Karen E ^a   Williams, David A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colocalization; Fibronectin; Gene transfer; Retrovirus mediated; VLA 4; VLA 5

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; INTEGRIN; RECOMBINANT PROTEIN; VERY LATE ACTIVATION ANTIGEN 5;

BINDING SITE; CELL ADHESION; GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPATHOLOGY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; RETROVIRUS; REVIEW; STEM CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD34; BINDING SITES; FIBRONECTINS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; PEPTIDE FRAGMENTS; PRIMATES; RECEPTORS, FIBRONECTIN; RECEPTORS, LYMPHOCYTE HOMING; RECOMBINANT PROTEINS; RETROVIRIDAE; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

EID: 0032692396     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Engel BC, Kohn DB: Stem cell directed gene therapy. Front Biosci (1999) 4:E26-E33.
2. Kerr WG: Genetic modification of the hematolymphoid compartment for therapeutic purposes. Hematol Oncol Clin North Am (1998) 12:503-518.
3. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF: T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 270:475-480.
4. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavillo F: Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science (1995) 270:470-475.
5. Moritz T, Keller DC, Williams DA: Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med (1993) 178:529-536.
6. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, el Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells In neonates with adenosine deaminase deficiency. Nature Med (1995) 1:1017-1023.
7. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancer (1993) 342:1134-1137.
8. Malech HL, Maples PB, Whiting-Theobald N, Linton GF, Sekhsaria S, Vowells SJ, Li F, Miller JA, DeCarlo E, Holland SM, Leitman SF, Carter CS, Butz RE, Read EJ, Fleisher TA, Schneiderman RD, Van Epps DE, Spratt SK, Maack CA, Rokovich JA, Cohen LK, Gallin JI: Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci USA (1997) 94:12133-12138.
9. + cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Hum Gene Ther (1998) 9:2629-2640.
10. Moore KA, Deisseroth AB, Reading CL, Williams DE, Belmont JW: Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Stood (1992) 79:1393-1399.
11. Yoder MC, Williams DA: Matrix molecule interactions with hematopoietic stem cells. Exp Hematol (1995) 23:961-967.
12. Moritz T, Patel VP, Williams DA: Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest (1994) 93:1451-1457.
13. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol (1990) 10:4239-4242.
14. Moritz T, Dutt P, Xiao X, Carstanjen D, Vik T, Hanenberg H, Williams DA: Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood (1996) 88:855-862.
15. Kimizuka F, Taguchi Y, Ohdate Y, Kawase Y, Shimojo T, Hashino K, Kato I, Sekiguchi K, Titani K: Production and characterization of functional domains of human fibronectin expressed in Escherichia coli. J Biochem (1991) 110:284-291.
16. Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA: Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Med (1996) 2:876-882.
17. Williams DA, Rios M, Stephens C, Patel VP: Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature (1991) 352:438-441.
18. Verfaille CM, McCarthy JB, McGlave PB: Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J Exp Med (1991) 174:693-703.
19. van der Loo JCM, Xiao X, McMillin D, Hashino K, Kato I, Williams DA: VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. J Clin Invest (1998) 102:1051-1061.
20. Hanenberg H, Hashino K, Konishi H, Hock RA, Kato I, Williams DA: Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum Gene Ther (1997) 8:2193-2206.
21. Kiem HP, Heyward S, Winkler A, Potter J, Allen JM, Miller AD, Andrews RG: Gene transfer into marrow repopulating cells: comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood (1997) 90:4638-4645.
22. Orlic D, Girard LJ, Anderson SM, Do BK, Seidel NE, Jordan CT, Bodine DM: Transduction efficiency of cell lines and hematopoietic stem cells correlates with retrovirus receptor mRNA levels. Stem Cells (1997) 15(Suppl 1):23-29.
23. Orlic D, Girard LJ, Anderson SM, Pyle LC, Yoder MC, Broxmeyer HE, Bodine DM: Identification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors. Blood (1998) 91:3247-3254.
24. MacNeill EC, Hanenberg H, Pollok KE, van der Loo JCM, Bierhuizen MFA, Wagemaker G, Williams DA: Simultaneous infection with retroviruses pseudotyped with different envelope proteins bypasses viral receptor interference associated with colocalization of gp70 and target cells on fibronectin CH-296. J Virol (1999) 73:3960-3967.
25. Abonour R, Einhorn L, Hromas R, Robertson MJ, Srour E, Traycoff CM, Bank A, Kato I, Asada K, Croop J, Smith FO, Williams DA, Cornetta K: Highly efficient MDR-1 gene transfer into humans using mobilized CD34+ cells transduced over recombinant fibronectin CH-296 fragment. Blood (1998) 92:690a.
26. Hege KM, Roberts MR: T-cell gene therapy. Curr Opin Biotechnol (1996) 7:629-634.
27. Culver K, Cornetta K, Morgan R, Morecki S, Aebersold P, Kasid A, Lotze M, Rosenberg SA, Anderson WF, Blaese RM: Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci USA (1991) 88:3155-3159.
28. Culver KW, Morgan RA, Osborne WRA, Lee RT, Lenschow D, Able C, Cornetta K, Anderson WF, Blaese RM: In vivo expression and survival of gene-modified T-lymphocytes in rhesus monkeys transplanted with retrovirus-infected bone marrow cells. Proc Natl Acad Sci USA (1990) 89:7640-7644.
29. Donahue RE, Bunnell BA, Zink MC, Metzger ME, Westro RP, Kirby MR, Unangst T, Clements JE, Morgan RA: Reduction of SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes. Nature Med (1998) 4:181-186.
30. Shimizu Y, van Seventer GA, Ennis E, Newman W, Horgan KJ, Shaw S: Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion. J Exp Med (1992) 175:577-582.
31. Pollok KE, van der Loo JCM, Cooper RJ, Kennedy L, Williams DA: Costimulation of transduced T-lymphocytes via T-cell receptor/CD3 complex and CD28 leads to increased transcription of integrated retrovirus. Hum Gene Ther (1999) in press.
32. Fehse B, Schade UM, Li Z, Uhde A, Koch S, Goller B, Rüger R, Fehse N, Stockschläder M, Zander AR: Highly efficient gene transfer with retroviral vectors into human T-lymphocytes on fibronectin. Br J Hematol (1998) 102:566-574.
33. Pollok KE, Hanenberg H, Noblitt TW, Schroeder WI, Kato I, Emanuel D, Williams DA: High-efficiency gene transfer into normal and adenosine deaminase-deficient T-lymphocytes Is mediated by transduction on recombinant fibronectin fragments. J Virol (1998) 72:4882-4892.
34. Williams DA, Lemischka IR, Nathan DG, Mulligan RC: Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature (1984) 310:476-480.
35. Szilvassy SJ, Fraser CC, Eaves CJ, Lansdorp PM, Eaves AC, Humphries RK: Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lymphomyelopoietic repopulating ability. Proc Natl Acad Sci USA (1989) 86:8798-8802.
36. Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A, Nienhuis AW: Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science (1992) 257:99-103.
37. Einerhand MP, Bakx TA, Kukler A, Valerio D: Factors affecting the transduction of pluripotent hematopoietic stem cells: Long-term expression of a human adenosine deaminase gene in mice. Blood (1993) 81:254-263.
38. Larochelle A, Vormoor J, Hanenberg H, Wang JCY, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, Williams DA, Dick JE: Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nature Med (1996) 2:1329-1337.
39. Cashman JD, Lapidot T, Wang JCY, Doedens M, Shultz LD, Lansdorp P, Dick JE, Eaves CJ: Kinetic evidence of the regeneration of multi-lineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood (1997) 89:4307-4316.
40. Conneally E, Eaves CJ, Humphries RK: Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood (1998) 9:3487-3493.
41. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE: A newly discovered class of hematopoietic cells with SCID-repopulating activity. Nature Med (1998) 4:1038-1045.
42. Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE: Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminshed long-term repopulating activity. Blood (1998) 92:1131-1141.
43. Dao MA, Hashino K, Kato I, Nolta JA: Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood (1998) 92:4612-4621.
44. Ponnazhagan V, Traycoff CM, Williams DA, McMahel J, Rice S, Cornetta K, Srour EF: Delayed targeting of cytokine-nonresponsive human bone marrow CD34+ cells with retrovirus-mediated gene transfer enhances transduction efficiency and long-term expression of transduced genes. Blood (1998) 10:3693-3701.
45. Schilz AJ, Brouns G, Knöss H, Ottmann OG, Heolzer D, Fauser AA, Thrasher AJ, Grez M: High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. Blood (1998) 92:3163-3171.
46. Rebel VI, Tanaka M, Lee J-S, Hartnett S, Pulsipher M, Nathan DG, Mulligan RC, Sieff CA: One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus. Blood (1999) 93:2217-2224.
47. Kiem H-P, Andrews RG, Morris J, Peterson L, Heyward S, Allen JM, Rasko JEJ, Potter J, Miller AD: Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, Fit-3 ligand, and megakaryocyte growth and development factor. Blood (1998) 92:1878-1886.
48. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE: Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science (1999) 283:682-686.
49. Case SS, Price MA, Jordan CT, Yu XJ, Wang L, Bauer G, Haas DL, Xu D, Stripecke R, Naldini L, Kohn DB, Crooks GM: Stable transduction of quiescent CD34+CD38- human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci USA (1999) 96:2988-2993.
50. Douglas J, Kelly P, Evans JT, Garcia JV: Efficient transduction of human lymphocytes and CD34+ cells via human immuodeficiency virus-based gene transfer vectors. Hum Gene Ther (1999) 10:935-945.
51. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 272:263-267.
52. Asada K, Uemori T, Ueno T, Hashino K, Koyama N, Kawamura A, Kato I: Enhancement of retroviral gene transduction on a dish coated with a cocktail of two different polypeptides: one exhibiting binding activity toward target cells, and the other toward retroviral vectors. J Biochem (1998) 123:1041-1047.